The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival.
Toxoplasma gondii is an intracellular parasite that persistently infects the CNS and that has genetically distinct strains which provoke different acute immune responses. How differences in the acute immune response affect the CNS immune response is unknown. To address this question, we used two per...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-10-01
|
Series: | PLoS Pathogens |
Online Access: | https://doi.org/10.1371/journal.ppat.1007856 |
id |
doaj-ba0de56f6ca84c8ea5692fc8ed9b07e2 |
---|---|
record_format |
Article |
spelling |
doaj-ba0de56f6ca84c8ea5692fc8ed9b07e22021-04-21T17:43:07ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742019-10-011510e100785610.1371/journal.ppat.1007856The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival.Shraddha TuladharJoshua A KochanowskyApoorva BhaskaraYarah GhotmiSambamurthy ChandrasekaranAnita A KoshyToxoplasma gondii is an intracellular parasite that persistently infects the CNS and that has genetically distinct strains which provoke different acute immune responses. How differences in the acute immune response affect the CNS immune response is unknown. To address this question, we used two persistent Toxoplasma strains (type II and type III) and examined the CNS immune response at 21 days post infection (dpi). Contrary to acute infection studies, type III-infected mice had higher numbers of total CNS T cells and macrophages/microglia but fewer alternatively activated macrophages (M2s) and regulatory T cells (Tregs) than type II-infected mice. By profiling splenocytes at 5, 10, and 21 dpi, we determined that at 5 dpi type III-infected mice had more M2s while type II-infected mice had more pro-inflammatory macrophages and that these responses flipped over time. To test how these early differences influence the CNS immune response, we engineered the type III strain to lack ROP16 (IIIΔrop16), the polymorphic effector protein that drives the early type III-associated M2 response. IIIΔrop16-infected mice showed a type II-like neuroinflammatory response with fewer infiltrating T cells and macrophages/microglia and more M2s and an unexpectedly low CNS parasite burden. At 5 dpi, IIIΔrop16-infected mice showed a mixed inflammatory response with more pro-inflammatory macrophages, M2s, T effector cells, and Tregs, and decreased rates of infection of peritoneal exudative cells (PECs). These data suggested that type III parasites need the early ROP16-associated M2 response to avoid clearance, possibly by the Immunity-Related GTPases (IRGs), which are IFN-γ- dependent proteins essential for murine defenses against Toxoplasma. To test this possibility, we infected IRG-deficient mice and found that IIIΔrop16 parasites now maintained parental levels of PECs infection. Collectively, these studies suggest that, for the type III strain, rop16III plays a key role in parasite persistence and influences the subacute CNS immune response.https://doi.org/10.1371/journal.ppat.1007856 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Shraddha Tuladhar Joshua A Kochanowsky Apoorva Bhaskara Yarah Ghotmi Sambamurthy Chandrasekaran Anita A Koshy |
spellingShingle |
Shraddha Tuladhar Joshua A Kochanowsky Apoorva Bhaskara Yarah Ghotmi Sambamurthy Chandrasekaran Anita A Koshy The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. PLoS Pathogens |
author_facet |
Shraddha Tuladhar Joshua A Kochanowsky Apoorva Bhaskara Yarah Ghotmi Sambamurthy Chandrasekaran Anita A Koshy |
author_sort |
Shraddha Tuladhar |
title |
The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. |
title_short |
The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. |
title_full |
The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. |
title_fullStr |
The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. |
title_full_unstemmed |
The ROP16III-dependent early immune response determines the subacute CNS immune response and type III Toxoplasma gondii survival. |
title_sort |
rop16iii-dependent early immune response determines the subacute cns immune response and type iii toxoplasma gondii survival. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS Pathogens |
issn |
1553-7366 1553-7374 |
publishDate |
2019-10-01 |
description |
Toxoplasma gondii is an intracellular parasite that persistently infects the CNS and that has genetically distinct strains which provoke different acute immune responses. How differences in the acute immune response affect the CNS immune response is unknown. To address this question, we used two persistent Toxoplasma strains (type II and type III) and examined the CNS immune response at 21 days post infection (dpi). Contrary to acute infection studies, type III-infected mice had higher numbers of total CNS T cells and macrophages/microglia but fewer alternatively activated macrophages (M2s) and regulatory T cells (Tregs) than type II-infected mice. By profiling splenocytes at 5, 10, and 21 dpi, we determined that at 5 dpi type III-infected mice had more M2s while type II-infected mice had more pro-inflammatory macrophages and that these responses flipped over time. To test how these early differences influence the CNS immune response, we engineered the type III strain to lack ROP16 (IIIΔrop16), the polymorphic effector protein that drives the early type III-associated M2 response. IIIΔrop16-infected mice showed a type II-like neuroinflammatory response with fewer infiltrating T cells and macrophages/microglia and more M2s and an unexpectedly low CNS parasite burden. At 5 dpi, IIIΔrop16-infected mice showed a mixed inflammatory response with more pro-inflammatory macrophages, M2s, T effector cells, and Tregs, and decreased rates of infection of peritoneal exudative cells (PECs). These data suggested that type III parasites need the early ROP16-associated M2 response to avoid clearance, possibly by the Immunity-Related GTPases (IRGs), which are IFN-γ- dependent proteins essential for murine defenses against Toxoplasma. To test this possibility, we infected IRG-deficient mice and found that IIIΔrop16 parasites now maintained parental levels of PECs infection. Collectively, these studies suggest that, for the type III strain, rop16III plays a key role in parasite persistence and influences the subacute CNS immune response. |
url |
https://doi.org/10.1371/journal.ppat.1007856 |
work_keys_str_mv |
AT shraddhatuladhar therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT joshuaakochanowsky therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT apoorvabhaskara therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT yarahghotmi therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT sambamurthychandrasekaran therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT anitaakoshy therop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT shraddhatuladhar rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT joshuaakochanowsky rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT apoorvabhaskara rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT yarahghotmi rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT sambamurthychandrasekaran rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival AT anitaakoshy rop16iiidependentearlyimmuneresponsedeterminesthesubacutecnsimmuneresponseandtypeiiitoxoplasmagondiisurvival |
_version_ |
1714665844552761344 |